BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

292 related articles for article (PubMed ID: 35062247)

  • 21. Staffing and Protective Equipment Access Mitigated COVID-19 Penetration and Spread in US Nursing Homes During the Third Surge.
    Simoni-Wastila L; Wallem A; Fleming SP; Le TT; Kepczynska P; Yang J; Qato DM
    J Am Med Dir Assoc; 2021 Dec; 22(12):2504-2510. PubMed ID: 34678266
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Factors influencing SARS-CoV-2 infection rate in Belgian nursing home residents during the first wave of COVID-19 pandemic.
    Peckeu-Abboud L; van Kleef E; Smekens T; Latour K; Dequeker S; Int Panis L; Laga M
    Epidemiol Infect; 2022 Feb; 150():e72. PubMed ID: 35403594
    [TBL] [Abstract][Full Text] [Related]  

  • 23. High SARS-CoV-2 Seroprevalence in Rural Peru, 2021: a Cross-Sectional Population-Based Study.
    Moreira-Soto A; Pachamora Diaz JM; González-Auza L; Merino Merino XJ; Schwalb A; Drosten C; Gotuzzo E; Talledo M; Arévalo Ramirez H; Peralta Delgado R; Bocanegra Vargas S; Drexler JF
    mSphere; 2021 Dec; 6(6):e0068521. PubMed ID: 34817236
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Association Between Nursing Home Crowding and COVID-19 Infection and Mortality in Ontario, Canada.
    Brown KA; Jones A; Daneman N; Chan AK; Schwartz KL; Garber GE; Costa AP; Stall NM
    JAMA Intern Med; 2021 Feb; 181(2):229-236. PubMed ID: 33165560
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Assessing the Pre-Vaccination Anti-SARS-CoV-2 IgG Seroprevalence among Residents and Staff in Nursing Home in Niigata, Japan, November 2020.
    Wagatsuma K; Yoshioka S; Yamazaki S; Sato R; Phyu WW; Chon I; Takahashi Y; Watanabe H; Saito R
    Viruses; 2022 Nov; 14(11):. PubMed ID: 36423190
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Early Acceleration of COVID-19 in Areas with Larger Nursing Homes and Certificate of Need Laws.
    Kosar CM; Rahman M
    J Gen Intern Med; 2021 Apr; 36(4):990-997. PubMed ID: 33511570
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Facility-Wide Testing for SARS-CoV-2 in Nursing Homes - Seven U.S. Jurisdictions, March-June 2020.
    Hatfield KM; Reddy SC; Forsberg K; Korhonen L; Garner K; Gulley T; James A; Patil N; Bezold C; Rehman N; Sievers M; Schram B; Miller TK; Howell M; Youngblood C; Ruegner H; Radcliffe R; Nakashima A; Torre M; Donohue K; Meddaugh P; Staskus M; Attell B; Biedron C; Boersma P; Epstein L; Hughes D; Lyman M; Preston LE; Sanchez GV; Tanwar S; Thompson ND; Vallabhaneni S; Vasquez A; Jernigan JA
    MMWR Morb Mortal Wkly Rep; 2020 Aug; 69(32):1095-1099. PubMed ID: 32790655
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Seroprevalence of anti-SARS-CoV-2 IgG antibodies in the staff of a public school system in the midwestern United States.
    Lopez L; Nguyen T; Weber G; Kleimola K; Bereda M; Liu Y; Accorsi EK; Skates SJ; Santa Maria JP; Smith KR; Kalinich M
    PLoS One; 2021; 16(6):e0243676. PubMed ID: 34111144
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Severe Acute Respiratory Syndrome Coronavirus 2 Seropositivity among Healthcare Personnel in Hospitals and Nursing Homes, Rhode Island, USA, July-August 2020.
    Akinbami LJ; Chan PA; Vuong N; Sami S; Lewis D; Sheridan PE; Lukacs SL; Mackey L; Grohskopf LA; Patel A; Petersen LR
    Emerg Infect Dis; 2021 Mar; 27(3):823-834. PubMed ID: 33622481
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Risk Factors Associated With SARS-CoV-2 Seropositivity Among US Health Care Personnel.
    Jacob JT; Baker JM; Fridkin SK; Lopman BA; Steinberg JP; Christenson RH; King B; Leekha S; O'Hara LM; Rock P; Schrank GM; Hayden MK; Hota B; Lin MY; Stein BD; Caturegli P; Milstone AM; Rock C; Voskertchian A; Reddy SC; Harris AD
    JAMA Netw Open; 2021 Mar; 4(3):e211283. PubMed ID: 33688967
    [TBL] [Abstract][Full Text] [Related]  

  • 31. COVID-19 testing in outbreak-free care homes: what are the public health benefits?
    Green R; Tulloch JSP; Tunnah C; Coffey E; Lawrenson K; Fox A; Mason J; Barnett R; Constantine A; Shepherd W; Ashton M; Beadsworth MBJ; Vivancos R; Hall I; Walker N; Ghebrehewet S
    J Hosp Infect; 2021 May; 111():89-95. PubMed ID: 33453349
    [TBL] [Abstract][Full Text] [Related]  

  • 32. SARS-CoV-2 seroprevalence in children, parents and school personnel from June 2020 to April 2021: cohort study of 55 schools in Switzerland.
    Ulyte A; Haile SR; Blankenberger J; Radtke T; Puhan MA; Kriemler S
    Swiss Med Wkly; 2022 Jun; 152():w30193. PubMed ID: 35752960
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Seroprevalence of Severe Acute Respiratory Syndrome Coronavirus 2 Among Skilled Nursing Facility Residents and Staff Members-Los Angeles County, August-September 2020.
    Malenfant JH; Eslami M; Dao BL; Moore L; Green N; Silver D; OYong K; Ruparelia A; Fisher R; Wood JS; Faisal M; Washburn F; Shvartsblat S; Jewell MP; Romo T; Foo C; Salazar A; Aguirre S; Balter S; Bhaurla S; Buenrrostro S; Bui K; Cho KY; Chun K; Civen R; Clarke A; Danza P; Fernandes P; Fountas N; Gambon M; Gragnani CM; Griffin A; Guerra L; Guerrero A; Hooshmand K; Claire Jarashow M; Knight W; Kuo AA; Ngo T; Nunez DM; Obara A; Rawson K; Terashita D; Rajagopalan S; Rubin ZA; Gounder P
    J Infect Dis; 2022 Feb; 225(3):367-373. PubMed ID: 34031692
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Non-occupational and occupational factors associated with specific SARS-CoV-2 antibodies among hospital workers - A multicentre cross-sectional study.
    Kahlert CR; Persi R; Güsewell S; Egger T; Leal-Neto OB; Sumer J; Flury D; Brucher A; Lemmenmeier E; Möller JC; Rieder P; Stocker R; Vuichard-Gysin D; Wiggli B; Albrich WC; Babouee Flury B; Besold U; Fehr J; Kuster SP; McGeer A; Risch L; Schlegel M; Friedl A; Vernazza P; Kohler P
    Clin Microbiol Infect; 2021 Sep; 27(9):1336-1344. PubMed ID: 34020033
    [TBL] [Abstract][Full Text] [Related]  

  • 35. National cross-sectional survey of 1.14 million NHS staff SARS-CoV-2 serology tests: a comparison of NHS staff with regional community seroconversion rates.
    Coltart CEM; Wells D; Sutherland E; Fowler A
    BMJ Open; 2021 Jul; 11(7):e049703. PubMed ID: 34257096
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Comprehensive infection control measures prevent hospital-acquired severe acute respiratory syndrome coronavirus 2 infection: A single-center prospective cohort study and seroprevalence survey.
    Hori H; Fukuchi T; Sanui M; Moriya T; Sugawara H
    PLoS One; 2021; 16(10):e0257513. PubMed ID: 34634076
    [TBL] [Abstract][Full Text] [Related]  

  • 37. High impact of COVID-19 outbreak in a nursing home in the Nouvelle-Aquitaine region, France, March to April 2020.
    Bernadou A; Bouges S; Catroux M; Rigaux JC; Laland C; Levêque N; Noury U; Larrieu S; Acef S; Habold D; Cazenave-Roblot F; Filleul L
    BMC Infect Dis; 2021 Feb; 21(1):198. PubMed ID: 33618660
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Association of COVID-19 Vaccination Rates of Staff and COVID-19 Illness and Death Among Residents and Staff in US Nursing Homes.
    Sinha S; Konetzka RT
    JAMA Netw Open; 2022 Dec; 5(12):e2249002. PubMed ID: 36580329
    [TBL] [Abstract][Full Text] [Related]  

  • 39. SARS-CoV-2 seroprevalence in healthcare workers in a high-volume ophthalmology centre in Guatemala.
    Davila-Siliezar P; Wer A; Barnoya J
    Ann Med; 2021 Dec; 53(1):1956-1959. PubMed ID: 34727801
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Impact of the COVID-19 pandemic on the homeless: results from a retrospective closed cohort in France (March-May 2020).
    Husain M; Rachline A; Cousien A; Rolland S; Rouzaud C; Ferre VM; Gomez MV; Le Teurnier M; Wicky-Thisse M; Descamps D; Yazdanpanah Y; Charpentier C; Pasquet-Cadre A
    Clin Microbiol Infect; 2021 Oct; 27(10):1520.e1-1520.e5. PubMed ID: 34111590
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.